CantaluppiA., NorthupS.J.Qualità ed efficacia delle soluzioni e dei contenitori per dialisi peritoneale. In: Di PaoloN., ed. CAPD, 2nd ed.Cosenza: Bios, 1991: 211.
9.
Di PaoloN., SacchiG.Peritoneal vascular changes in CAPD: an in vivo model for the study of diabetic microangiopathy.Perit Dial Int1989; 9: 41.
10.
Di PaoloN., GarosiG., RossiP., CapotondoL., Di PaoloM.A new method of evaluating urinary erythrocyte dysmorphism (UED) in glomerulonephritis.Clin Nephrol1993; 39: 50.
11.
BreborowiczA., SombolosK., RodelaH.Mechanism of phosphatidylcholine action during peritoneal dialysis.Nephron1986; 44: 365.
12.
DobbieJ.W., PavlinaT., LloydJ.Phosphatidylcholine synthesis by peritoneal mesothelium: its implication for peritoneal dialysis.Am J Kidney Dis1988; 12: 31.
13.
SatohK., PrescottS.M.Culture of mesothelial cells from bovine pericardium and characterization of their arachidonate metabolism.Biochim Biophys Acta1987; 930: 283.
14.
DustingG.I., NolanR.D., WoodmanO.L., MartinT.J.Prostacyclin produced by the pericardium and its influence on coronary vascular tone.Am J Cardiol1983; 52: 28.
15.
Di PaoloN., GarosiG., GuarnieriA., GaggiottiE., Di PaoloM.Biocompatibility of peritoneal dialysis solutions (PDS) containing bicarbonate buffer (BB). Thirtieth Congress of the European Dialysis and Transplant Association, European Renal AssociationGlasgow, 1993: 188.
16.
Di PaoloN., GarosiG., GuarnieriA., GaggiottiE., Di PaoloM.Use of a glucose substitute, gluconic acid, in peritoneal dialysis solutions (PDS). Thirtieth Congress of the European Dialysis and Transplant Association, European Renal AssociationGlasgow, 1993: 188.